Aideen M Sullivan Selected Research

Nerve Growth Factors (Neurotrophins)

1/2022	Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
8/2020	The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease.
1/2019	Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein.
11/2018	Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease.
5/2017	Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysis.
2/2016	Neurotrophic factor therapy for Parkinson's disease: past, present and future.
5/2015	Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.
10/2014	Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease.
10/2014	Roles for the TGFβ superfamily in the development and survival of midbrain dopaminergic neurons.
10/2012	Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aideen M Sullivan Research Topics

Disease

45	Parkinson Disease (Parkinson's Disease) 05/2022 - 02/2004
9	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022 - 02/2005
5	Disease Progression 01/2022 - 08/2008
4	Neuroblastoma 04/2020 - 07/2017
2	Neoplasms (Cancer) 01/2019 - 07/2017
2	Cognitive Dysfunction 01/2018 - 04/2017
2	Inflammation (Inflammations) 03/2013 - 11/2009
2	Necrosis 01/2010 - 11/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2022
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Brain Injuries (Brain Injury) 10/2020
1	Wounds and Injuries (Trauma) 03/2012
1	Human Influenza (Influenza) 11/2009
1	Infections 11/2009
1	Bacterial Vaginosis 11/2009

Drug/Important Bio-Agent (IBA)

16	SynucleinsIBA 05/2022 - 11/2016
14	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 02/2004
6	Growth Differentiation Factor 5IBA 01/2022 - 02/2004
5	Oxidopamine (6 Hydroxydopamine)IBA 01/2022 - 02/2004
4	Neuroprotective AgentsIBA 01/2018 - 02/2004
3	NeurotoxinsIBA 01/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 12/2008
3	Cytotoxins (Cytolysins)IBA 01/2019 - 07/2017
2	Histone Deacetylase InhibitorsIBA 01/2022 - 07/2017
2	MC1568IBA 01/2022 - 01/2019
2	alpha-SynucleinIBA 01/2021 - 12/2008
2	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2020
2	Bone Morphogenetic Protein ReceptorsIBA 08/2020 - 04/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 06/2020 - 07/2017
2	Pharmaceutical PreparationsIBA 07/2017 - 08/2008
2	Histones (Histone)IBA 07/2017 - 10/2016
2	CytokinesIBA 01/2010 - 11/2009
1	NeurturinIBA 08/2020
1	Bone Morphogenetic Protein 2IBA 08/2020
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 08/2020
1	Protein AggregatesIBA 01/2020
1	phosphoinositide-3,4,5-triphosphateIBA 10/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2019
1	LipidsIBA 10/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	isoliquiritigenin (GU 17)IBA 01/2019
1	4-hydroxychalconeIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	FlavonoidsIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	romidepsin (FK228)FDA Link 07/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017
1	CaspasesIBA 07/2017
1	AS 35IBA 07/2017
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 04/2017
1	Messenger RNA (mRNA)IBA 12/2016
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 10/2016
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2013
1	Transcription Factors (Transcription Factor)IBA 03/2013
1	LigandsIBA 03/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2008
1	UbiquitinIBA 12/2008
1	Levodopa (L Dopa)FDA LinkGeneric 08/2008
1	Therapeutic UsesIBA 02/2004

Therapy/Procedure

14	Therapeutics 01/2022 - 08/2008
4	Transplantation 10/2012 - 02/2005
3	Cell Transplantation 10/2014 - 03/2012
2	Drug Therapy (Chemotherapy) 07/2021 - 07/2017